{"news_desk": "Business", "print_page": null, "subsection_name": null, "section_name": "Business Day", "byline": {"contributor": "", "original": "By REUTERS", "person": [], "organization": "REUTERS"}, "abstract": null, "type_of_material": "News", "word_count": "261", "keywords": [{"rank": "1", "value": "GlaxoSmithKline PLC", "is_major": "N", "name": "organizations"}, {"rank": "2", "value": "Bribery and Kickbacks", "is_major": "N", "name": "subject"}, {"rank": "3", "value": "Foreign Corrupt Practices Act (1977)", "is_major": "N", "name": "subject"}, {"rank": "4", "value": "Securities and Exchange Commission", "is_major": "N", "name": "organizations"}, {"rank": "5", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "name": "subject"}, {"rank": "6", "value": "China", "is_major": "N", "name": "glocations"}], "lead_paragraph": "The Securities and Exchange Commission said the company disguised bribes to foreign officials as legitimate travel, entertainment and marketing expenses.", "pub_date": "2016-10-01T04:00:00+0000", "document_type": "article", "source": "The New York Times", "snippet": "The Securities and Exchange Commission said the company disguised bribes to foreign officials as legitimate travel, entertainment and marketing expenses....", "multimedia": [], "web_url": "http://www.nytimes.com/2016/10/01/business/glaxo-to-pay-20-million-to-settle-us-bribery-case-in-china.html", "slideshow_credits": null, "blog": [], "_id": "57eeca2d95d0e021d79896ee", "headline": {"main": "Glaxo to Pay $20 Million to Settle U.S. Bribery Case in China"}}